BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 26320419)

  • 1. DNA vaccine encoding the moonlighting protein Onchocerca volvulus glyceraldehyde-3-phosphate dehydrogenase (Ov-GAPDH) leads to partial protection in a mouse model of human filariasis.
    Steisslinger V; Korten S; Brattig NW; Erttmann KD
    Vaccine; 2015 Oct; 33(43):5861-5867. PubMed ID: 26320419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning, characterization and DNA immunization of an Onchocerca volvulus glyceraldehyde-3-phosphate dehydrogenase (Ov-GAPDH).
    Erttmann KD; Kleensang A; Schneider E; Hammerschmidt S; Büttner DW; Gallin M
    Biochim Biophys Acta; 2005 Jun; 1741(1-2):85-94. PubMed ID: 15955451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of a recombinant plasmid harbouring the glyceraldenyde-3-phosphate dehydrogenase gene of periodic Brugia malayi and observation on DNA immunity.
    Fang Z; Tong H; Zhang S; Fang H; Lu S; Xu B
    Indian J Med Microbiol; 2012; 30(2):193-7. PubMed ID: 22664436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination of Gerbils with Bm-103 and Bm-RAL-2 Concurrently or as a Fusion Protein Confers Consistent and Improved Protection against Brugia malayi Infection.
    Arumugam S; Wei J; Liu Z; Abraham D; Bell A; Bottazzi ME; Hotez PJ; Zhan B; Lustigman S; Klei TR
    PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004586. PubMed ID: 27045170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody responses against the vaccine antigens Ov-103 and Ov-RAL-2 are associated with protective immunity to Onchocerca volvulus infection in both mice and humans.
    George PJ; Hess JA; Jain S; Patton JB; Zhan T; Tricoche N; Zhan B; Bottazzi ME; Hotez PJ; Abraham D; Lustigman S
    PLoS Negl Trop Dis; 2019 Sep; 13(9):e0007730. PubMed ID: 31525197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of a filarial phosphate permease that is up-regulated in response to depletion of essential Wolbachia endobacteria.
    Arumugam S; Hoerauf A; Pfarr KM
    Exp Parasitol; 2014 Mar; 138():30-9. PubMed ID: 24480589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Immunomodulatory Role of Adjuvants in Vaccines Formulated with the Recombinant Antigens Ov-103 and Ov-RAL-2 against Onchocerca volvulus in Mice.
    Hess JA; Zhan B; Torigian AR; Patton JB; Petrovsky N; Zhan T; Bottazzi ME; Hotez PJ; Klei TR; Lustigman S; Abraham D
    PLoS Negl Trop Dis; 2016 Jul; 10(7):e0004797. PubMed ID: 27387453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization with L. sigmodontis microfilariae reduces peripheral microfilaraemia after challenge infection by inhibition of filarial embryogenesis.
    Ziewer S; Hübner MP; Dubben B; Hoffmann WH; Bain O; Martin C; Hoerauf A; Specht S
    PLoS Negl Trop Dis; 2012; 6(3):e1558. PubMed ID: 22413031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a recombinant antigen vaccine against infection with the filarial worm Onchocerca volvulus.
    Abraham D; Leon O; Leon S; Lustigman S
    Infect Immun; 2001 Jan; 69(1):262-70. PubMed ID: 11119514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA immunization with Onchocerca volvulus genes, Ov-tmy-1 and OvB20: serological and parasitological outcomes following intramuscular or GeneGun delivery in a mouse model of onchocerciasis.
    Harrison RA; Bianco AE
    Parasite Immunol; 2000 May; 22(5):249-57. PubMed ID: 10792764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA immunisation with Onchocerca volvulus chitinase induces partial protection against challenge infection with L3 larvae in mice.
    Harrison RA; Wu Y; Egerton G; Bianco AE
    Vaccine; 1999 Nov; 18(7-8):647-55. PubMed ID: 10547424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-Administration of Adjuvanted Recombinant
    Luu L; Bah GS; Okah-Nnane NH; Hartley CS; Glover AF; Walsh TR; Lian LY; Zhan B; Bottazzi ME; Abraham D; Petrovsky N; Bayang N; Tangwa B; Ayiseh RB; Mbah GE; Ekale DD; Tanya VN; Lustigman S; Makepeace BL; Graham-Brown J
    Vaccines (Basel); 2022 May; 10(6):. PubMed ID: 35746469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune recognition of Onchocerca volvulus proteins in the human host and animal models of onchocerciasis.
    Manchang TK; Ajonina-Ekoti I; Ndjonka D; Eisenbarth A; Achukwi MD; Renz A; Brattig NW; Liebau E; Breloer M
    J Helminthol; 2015 May; 89(3):375-86. PubMed ID: 24721822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid profiling of the filarial nematodes Onchocerca volvulus, Onchocerca ochengi and Litomosoides sigmodontis reveals the accumulation of nematode-specific ether phospholipids in the host.
    Wewer V; Makepeace BL; Tanya VN; Peisker H; Pfarr K; Hoerauf A; Dörmann P
    Int J Parasitol; 2017 Dec; 47(14):903-912. PubMed ID: 28743489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of parasite immune modulatory sequences combined with immune activating signals enhances vaccine mediated protection against filarial nematodes.
    Babayan SA; Luo H; Gray N; Taylor DW; Allen JE
    PLoS Negl Trop Dis; 2012; 6(12):e1968. PubMed ID: 23301106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a recombinant vaccine against human onchocerciasis.
    Abraham D; Graham-Brown J; Carter D; Gray SA; Hess JA; Makepeace BL; Lustigman S
    Expert Rev Vaccines; 2021 Nov; 20(11):1459-1470. PubMed ID: 34488533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional characterization and immune recognition of the extracellular superoxide dismutase from the human pathogenic parasite Onchocerca volvulus (OvEC-SOD).
    Ajonina-Ekoti I; Ndjonka D; Tanyi MK; Wilbertz M; Younis AE; Boursou D; Kurosinski MA; Eberle R; Lüersen K; Perbandt M; Breloer M; Brattig NW; Liebau E
    Acta Trop; 2012 Oct; 124(1):15-26. PubMed ID: 22677600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the antibody response elicited by immunization with pneumococcal surface protein A (PspA) as recombinant protein or DNA vaccine and analysis of protection against an intranasal lethal challenge with Streptococcus pneumoniae.
    Vadesilho CF; Ferreira DM; Moreno AT; Chavez-Olortegui C; Machado de Avila RA; Oliveira ML; Ho PL; Miyaji EN
    Microb Pathog; 2012; 53(5-6):243-9. PubMed ID: 22981893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of immune response elicited by inulin as an adjuvant with filarial antigens in mice model.
    Mahalakshmi N; Aparnaa R; Kaliraj P
    Scand J Immunol; 2014 Oct; 80(4):261-70. PubMed ID: 25041426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization with Brugia malayi Hsp70 protects mice against Litomosoides sigmodontis challenge infection.
    Hartmann W; Singh N; Rathaur S; Brenz Y; Liebau E; Fleischer B; Breloer M
    Parasite Immunol; 2014 Apr; 36(4):141-9. PubMed ID: 24359133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.